Stay updated with breaking news from Matthew ballo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure Limited (NASDAQ:NVCR) Q3 2023 Earnings Call Transcript October 26, 2023 NovoCure Limited beats earnings expectations. Reported EPS is $-0.46, expectations were $-0.52. Operator: Welcome to the NovoCure Q3 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your […] ....
Novocure today announced its participation in the upcoming American Society for Radiation Oncology 2023 Annual Meeting from October 1 – 4 in San Diego. Presentations will describe preclinical,. ....
Novocure (NASDAQ:NVCR) today announced its participation in the upcoming American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting from October 1 – 4 in San Diego. Presentations will describe preclinical, ....
ROOT, Switzerland, September 29, 2023 Novocure (NASDAQ: NVCR) today announced its participation in the upcoming American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting from October 1 – 4 in San Diego. Presentations will describe preclinical, clinical and simulation modeling studies on Tumor Treating Fields (TTFields) therapy, including new insights about methods to optimize TTFields intensities delivered at the target tumor during treatment. ....